USPTO serial 99728294
PAI PHARMA
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- BYRNE, JODIE A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PAI PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Parsippany, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey T. Stover
Jeffrey T. Stover Haynsworth Sinkler Boyd, P.A.134 Meeting Street, Suite 300Charleston, SC 29401United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | A house mark for liquid generic pharmaceuticals, namely, preparations for treating urinary conditions, antacids, antibiotics, anticholinergics, anticonvulsants, antidepressants, antidiarrheals, antifungal preparations, antihistamines, anti-inflammatory agents, antinauseants, antipsychotics, antipyretics, antispasmodics, antivirals, anxiolytics, appetite stimulants, barbiturates, bladder relaxants, bronchodilators, cold treatment preparations, cough treatment preparations, cough and cold treatment preparations with and without prescription narcotics, histamine 2 blockers, hypnotics, internal analgesics, laxatives, motion sickness treatment preparations, prescription narcotic pain relievers, prescription opioid pain relievers, hematinic nutritional supplement preparations, pain relief medication, preparations for the treatment of pneumonia, potassium vitamin supplements, progestogens, sedatives, sennosides, systemic corticoids and preparations for the treatment of ulcers, sold in unit-dose packages | ACTIVE | Feb 27, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 9, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 8, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 8, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 8, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 8, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 30, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 31, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 31, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 5, 2026 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 5, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 27, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 27, 2026 | NWAP | NEW APPLICATION ENTERED | — |